Hepcidin Antimicrobial Peptide Antibody (968001) [Alexa Fluor® 532]

• Applications: ELISA
• Clone: 968001
• Clonality: Monoclonal
• Host: Rat
• Conjugate: Alexa Fluor 532

Hepcidin Antimicrobial Peptide Antibody (968001) [Alexa Fluor® 532] Summary

• Immunogen: Synthetic peptide containing mouse Hepcidin
  Accession # Q9EQ21
• Specificity: Detects mouse Hepcidin in direct ELISA.
• Source: N/A
• Isotype: IgG2a
• Clonality: Monoclonal
• Host: Rat
• Purity Statement: Protein A or G purified from cell culture supernatant

Applications/Dilutions

• Dilutions:
  • ELISA

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied
• Buffer: Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.

Notes

This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Hepcidin Antimicrobial Peptide Antibody (968001) [Alexa Fluor® 532]

• HAMP
• HEPC
• hepcidin antimicrobial peptide
• Hepcidin
• HEPCPutative liver tumor regressor
• HFE2B
• HFE2Bhepcidin
• LEAP1
• LEAP-1
• LEAP1PLTR
• Liver-expressed antimicrobial peptide 1
• PLTR

Background

Hepcidin, also known as Liver Expressed Antimicrobial Protein 1 (LEAP-1), is a peptide hormone that is involved in the regulation of iron metabolism (1, 2). It is synthesized as a preprohormone that is cleaved intracellularly and secreted as a mature 25 amino acid peptide (1, 3, 4). Hepcidin contains eight cysteine residues that form four disulfide bonds which appear to be important for stability in biological fluids (5). It is predominantly expressed, processed, and secreted by hepatocytes (2, 6). Hepcidin expression is positively regulated by inflammation via IL-6/JAK2/ STAT3 signaling, endoplasmic reticulum stress, and BMP-6 (7-11). BMP-6-dependent Hepcidin induction involves RGM-C/Hemojuvelin, which acts as a co-receptor for BMP-6 (11-13). Conversely, Hepcidin expression is negatively regulated by MMP‑15/MT2‑MMP and multiple erythropoietic stimuli, including anemia, hypoxia, and Erythropoietin (14-18). MMP-15 downregulates Hepcidin expression by interacting with and cleaving RGM-C (19). Hepcidin was originally identified in human blood and urine as an antimicrobial peptide (1, 3). It has since been shown to regulate iron metabolism. Hepcidin binds the cellular iron exporter Ferroportin, and this interaction results in Ubiquitin-mediated degradation of both Hepcidin and Ferroportin (20-22). Degradation of Ferroportin results in reduced iron release from macrophages, hepatocytes, and duodenal enterocytes, suggesting that Hepcidin may be an effector of inflammatory hypoferremia (20).

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Uniprot:
  • Q9EQ21()